Details for New Drug Application (NDA): 021231
✉ Email this page to a colleague
The generic ingredient in ZOMIG-ZMT is zolmitriptan. There are twenty drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the zolmitriptan profile page.
Summary for 021231
Tradename: | ZOMIG-ZMT |
Applicant: | Astrazeneca |
Ingredient: | zolmitriptan |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | 2.5MG | ||||
Approval Date: | Feb 13, 2001 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | 5MG | ||||
Approval Date: | Sep 17, 2001 | TE: | RLD: | Yes |
Expired US Patents for NDA 021231
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Astrazeneca | ZOMIG-ZMT | zolmitriptan | TABLET, ORALLY DISINTEGRATING;ORAL | 021231-001 | Feb 13, 2001 | ⤷ Sign Up | ⤷ Sign Up |
Astrazeneca | ZOMIG-ZMT | zolmitriptan | TABLET, ORALLY DISINTEGRATING;ORAL | 021231-002 | Sep 17, 2001 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription